Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Short-term evaluation of cardiac morphology, function, metabolism and structure following diagnosis of adult-onset growth hormone deficiency.

De Cobelli F, Rossini A, Esposito A, Canu T, Manzoni G, Del Maschio A, Rubinacci A, Sirtori M, Losa M, Lanzi R, Perseghin G.

Growth Horm IGF Res. 2019 Jun - Aug;46-47:50-54. doi: 10.1016/j.ghir.2019.06.003. Epub 2019 Jun 25.

PMID:
31276905
2.

Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study.

Fadini GP, Frison V, Simioni N, Lapolla A, Gatti A, Bossi AC, Del Buono A, Fornengo P, Gottardo L, Laudato M, Perseghin G, Bonora E, Avogaro A.

J Am Heart Assoc. 2019 Jul 16;8(14):e012244. doi: 10.1161/JAHA.119.012244. Epub 2019 Jul 4.

3.

Corrigendum to "Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population" [Nutr Metabol Cardiovasc Dis 29 (5) (May 2019) 496-503].

Bonadonna RC, Giaccari A, Buzzetti R, Aimaretti G, Cucinotta D, Avogaro A, Perseghin G, Larosa M, Bolli GB, Fanelli CG.

Nutr Metab Cardiovasc Dis. 2019 Aug;29(8):869-870. doi: 10.1016/j.numecd.2019.05.059. Epub 2019 Jun 27. No abstract available.

PMID:
31257093
4.

Adherence to clinical evaluations in women with pre-existing diabetes during pregnancy: A call to action from an Italian real-life investigation.

Cantarutti A, Rea F, Locatelli A, Merlino L, Lundin R, Perseghin G, Corrao G.

Diabetes Res Clin Pract. 2019 Aug;154:1-8. doi: 10.1016/j.diabres.2019.06.006. Epub 2019 Jun 17.

PMID:
31220483
5.

[Collaborative synergy in the management of diabetic patients with acute coronary syndrome].

Di Lenarda A, Candido R, Anichini R, Caldarola P, Comeglio M, Giordano R, Laviola L, Perseghin G, Polizzi GM, Provenzano V, Ricci R, Specchia G, Zicari S.

G Ital Cardiol (Rome). 2019 Jun;20(6):351-360. doi: 10.1714/3165.31468. Italian.

PMID:
31184321
6.

Fasting Whole-Body Energy Homeostasis and Hepatic Energy Metabolism in Nondiabetic Humans with Fatty Liver.

Lattuada G, Radaelli MG, De Cobelli F, Esposito A, Manzoni G, Perra S, Del Maschio A, Castoldi G, Perseghin G.

Oxid Med Cell Longev. 2019 Apr 11;2019:9796175. doi: 10.1155/2019/9796175. eCollection 2019.

7.

Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population.

Bonadonna RC, Giaccari A, Buzzetti R, Aimaretti G, Cucinotta D, Avogaro A, Perseghin G, Larosa M, Bolli GB, Fanelli CG.

Nutr Metab Cardiovasc Dis. 2019 May;29(5):496-503. doi: 10.1016/j.numecd.2019.01.011. Epub 2019 Feb 8. Erratum in: Nutr Metab Cardiovasc Dis. 2019 Aug;29(8):869-870.

PMID:
30952575
8.

Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats.

Castoldi G, di Gioia CRT, Roma F, Carletti R, Manzoni G, Stella A, Zerbini G, Perseghin G.

Acta Diabetol. 2019 Jan;56(1):97-104. doi: 10.1007/s00592-018-1220-1. Epub 2018 Sep 5.

PMID:
30187136
9.

[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018].

Volpe M, Tocci G, Accettura D, Battistoni A, Bellone S, Bellotti P, Bertolotti M, Borghi C, Casasco M, Consoli A, Coppini R, Corsini A, Costanzo G, Desideri G, Ferri C, Galanti G, Giada F, Icardi G, Lombardi N, Modena MG, Modesti PA, Monti G, Mugelli A, Orsi A, Parati G, Pedretti RF, Perseghin G, Pirro M, Ricotti R, Rizzoni D, Rotella C, Rubattu S, Salvetti G, Sarto P, Tassinari F, Trimarco B, de Kreutzenberg SV, Volpe R.

G Ital Cardiol (Rome). 2018 Feb;19(2 Suppl 1):1S-95S. doi: 10.1714/2874.28988. Italian.

PMID:
29531376
10.

Non-alcoholic fatty liver disease: A risk factor for myocardial dysfunction?

Byrne CD, Perseghin G.

J Hepatol. 2018 Apr;68(4):640-642. doi: 10.1016/j.jhep.2017.12.002. Epub 2017 Dec 10. No abstract available.

PMID:
29237547
11.

NAFLD/NASH in patients with type 2 diabetes and related treatment options.

Radaelli MG, Martucci F, Perra S, Accornero S, Castoldi G, Lattuada G, Manzoni G, Perseghin G.

J Endocrinol Invest. 2018 May;41(5):509-521. doi: 10.1007/s40618-017-0799-3. Epub 2017 Nov 30. Review.

PMID:
29189999
12.

Fertilizing a Patient Engagement Ecosystem to Innovate Healthcare: Toward the First Italian Consensus Conference on Patient Engagement.

Graffigna G, Barello S, Riva G, Savarese M, Menichetti J, Castelnuovo G, Corbo M, Tzannis A, Aglione A, Bettega D, Bertoni A, Bigi S, Bruttomesso D, Carzaniga C, Del Campo L, Donato S, Gilardi S, Guglielmetti C, Gulizia M, Lastretti M, Mastrilli V, Mazzone A, Muttillo G, Ostuzzi S, Perseghin G, Piana N, Pitacco G, Polvani G, Pozzi M, Provenzi L, Quaglini G, Rossi M, Varese P, Visalli N, Vegni E, Ricciardi W, Bosio AC.

Front Psychol. 2017 Jun 6;8:812. doi: 10.3389/fpsyg.2017.00812. eCollection 2017.

13.

Hypertension and hepatic triglycerides content: a two (multi)-faceted clinical challenge?

Perseghin G, Manzoni G, Grassi G.

J Hypertens. 2017 Apr;35(4):715-717. doi: 10.1097/HJH.0000000000001290. No abstract available.

PMID:
28248900
14.

The EMPA-REG outcome study: critical appraisal and potential clinical implications.

Perseghin G, Solini A.

Cardiovasc Diabetol. 2016 Jun 4;15:85. doi: 10.1186/s12933-016-0403-8. Review.

15.

Effects of short-term manipulation of serum FFA concentrations on left ventricular energy metabolism and function in patients with heart failure: no association with circulating bio-markers of inflammation.

Salerno A, Fragasso G, Esposito A, Canu T, Lattuada G, Manzoni G, Del Maschio A, Margonato A, De Cobelli F, Perseghin G.

Acta Diabetol. 2015 Aug;52(4):753-61. doi: 10.1007/s00592-014-0695-7. Epub 2015 Jan 7.

PMID:
25559351
16.

[Multidisciplinary management of patients with acute coronary syndrome and diabetes mellitus: from antithrombotic therapy to treatment of hyperglycemia].

Rossini R, Cimino A, De Servi S, Grieco N, Lettieri C, Mafrici A, Musumeci G, Perseghin G, Sponzilli C, Trevisan R, Visconti LO; nome della Sezione Lombarda dell’Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); della Società Italiana di Cardiologia Invasiva (GISE); dell’Associazione Medici Diabetologi (AMD) e della Società Italiana di Diabetologia (SID).

G Ital Cardiol (Rome). 2014 Jun;15(6):378-92. doi: 10.1714/1582.17284. Italian.

PMID:
25072424
17.

Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: systematic review and meta-analysis.

Kunutsor SK, Apekey TA, Van Hemelrijck M, Calori G, Perseghin G.

Int J Cancer. 2015 Mar 1;136(5):1162-70. doi: 10.1002/ijc.29084. Epub 2014 Aug 1. Review.

18.

MR-guided stereotactic breast biopsy using a mixed ferromagnetic-nonmagnetic coaxial system with 12- to 18-gauge needles: clinical experience and long-term outcome.

Belloni E, Panizza P, Ravelli S, De Cobelli F, Gusmini S, Losio C, Sassi I, Perseghin G, Del Maschio A.

Radiol Med. 2013 Oct;118(7):1137-48. doi: 10.1007/s11547-013-0954-7. Epub 2013 Jun 25.

PMID:
23801401
19.

Intraindividual comparison of gadobutrol and gadopentetate dimeglumine for detection of myocardial late enhancement in cardiac MRI.

De Cobelli F, Esposito A, Perseghin G, Sallemi C, Belloni E, Ravelli S, Lanzani C, Del Maschio A.

AJR Am J Roentgenol. 2012 Apr;198(4):809-16. doi: 10.2214/AJR.11.7118.

PMID:
22451545
20.

Beneficial effects of beta-blockers on left ventricular function and cellular energy reserve in patients with heart failure.

Spoladore R, Fragasso G, Perseghin G, De Cobelli F, Esposito A, Maranta F, Calori G, Locatelli M, Lattuada G, Scifo P, Del Maschio A, Margonato A.

Fundam Clin Pharmacol. 2013 Aug;27(4):455-64. doi: 10.1111/j.1472-8206.2012.01029.x. Epub 2012 Feb 9.

PMID:
22320703
21.

31P-magnetic resonance spectroscopy (31P-MRS) detects early changes in kidney high-energy phosphate metabolism during a 6-month Valsartan treatment in diabetic and non-diabetic kidney-transplanted patients.

Fiorina P, Bassi R, Gremizzi C, Vergani A, Caldara R, Mello A, Del Maschio A, De Cobelli F, Perseghin G, Secchi A.

Acta Diabetol. 2012 Dec;49 Suppl 1:S133-9.

PMID:
22302190
22.

Lipid accumulation in overweight type 2 diabetic subjects: relationships with insulin sensitivity and adipokines.

Sambataro M, Perseghin G, Lattuada G, Beltramello G, Luzi L, Pacini G.

Acta Diabetol. 2013 Jun;50(3):301-7. doi: 10.1007/s00592-011-0366-x. Epub 2012 Jan 4.

PMID:
22215127
23.

Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up.

Perseghin G, Calori G, Lattuada G, Ragogna F, Dugnani E, Garancini MP, Crosignani P, Villa M, Bosi E, Ruotolo G, Piemonti L.

Acta Diabetol. 2012 Dec;49(6):421-8. doi: 10.1007/s00592-011-0361-2. Epub 2012 Jan 4.

PMID:
22215126
24.

Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes.

Bonapace S, Perseghin G, Molon G, Canali G, Bertolini L, Zoppini G, Barbieri E, Targher G.

Diabetes Care. 2012 Feb;35(2):389-95. doi: 10.2337/dc11-1820. Epub 2011 Dec 30.

25.

Resting cardiac energy metabolism is inversely associated with heart rate in healthy young adult men.

Fragasso G, De Cobelli F, Spoladore R, Esposito A, Salerno A, Calori G, Montanaro C, Maranta F, Lattuada G, Margonato A, Del Maschio A, Perseghin G.

Am Heart J. 2011 Jul;162(1):136-41. doi: 10.1016/j.ahj.2011.04.012.

PMID:
21742100
26.

Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure.

Fragasso G, Salerno A, Lattuada G, Cuko A, Calori G, Scollo A, Ragogna F, Arioli F, Bassanelli G, Spoladore R, Luzi L, Margonato A, Perseghin G.

Heart. 2011 Sep;97(18):1495-500. doi: 10.1136/hrt.2011.226332. Epub 2011 Jun 23.

PMID:
21700755
27.

Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis.

Perseghin G.

Diabetes Care. 2011 May;34 Suppl 2:S367-70. doi: 10.2337/dc11-s249. Review. No abstract available.

28.

Fatty liver index and mortality: the Cremona study in the 15th year of follow-up.

Calori G, Lattuada G, Ragogna F, Garancini MP, Crosignani P, Villa M, Bosi E, Ruotolo G, Piemonti L, Perseghin G.

Hepatology. 2011 Jul;54(1):145-52. doi: 10.1002/hep.24356.

PMID:
21488080
29.

Increased low-grade inflammation is associated with lack of functional response to carvedilol in patients with systolic heart failure.

Fragasso G, Spoladore R, Maranta F, Corti A, Lattuada G, Colombo B, Locatelli M, Salerno A, Calori G, Briceno L, Alfieri AB, Perseghin G, Margonato A.

J Cardiovasc Med (Hagerstown). 2013 Jan;14(1):49-56. doi: 10.2459/JCM.0b013e328345a1f6.

PMID:
23018486
30.

Why does NAFLD predict type 2 diabetes?

Lattuada G, Ragogna F, Perseghin G.

Curr Diab Rep. 2011 Jun;11(3):167-72. doi: 10.1007/s11892-011-0190-2. Review.

PMID:
21431854
31.

Gender influence on dose saving allowed by prospective-triggered 64-slice multidetector computed tomography coronary angiography as compared with retrospective-gated mode.

Esposito A, De Cobelli F, Colantoni C, Perseghin G, Del Vecchio A, Canu T, Calandrino R, Del Maschio A.

Int J Cardiol. 2012 Jul 12;158(2):253-9. doi: 10.1016/j.ijcard.2011.01.039. Epub 2011 Feb 16.

PMID:
21324538
32.

Lack of association of apoE ε4 allele with insulin resistance.

Ragogna F, Lattuada G, Ruotolo G, Luzi L, Perseghin G.

Acta Diabetol. 2012 Feb;49(1):25-32. doi: 10.1007/s00592-011-0255-3. Epub 2011 Feb 3.

PMID:
21290252
33.

Exploring the in vivo mechanisms of action of glucokinase activators in type 2 diabetes.

Perseghin G.

J Clin Endocrinol Metab. 2010 Nov;95(11):4871-3. doi: 10.1210/jc.2010-2049. No abstract available.

PMID:
21051584
34.

Beta cell function during rapamycin monotherapy in long-term type 1 diabetes.

Piemonti L, Maffi P, Monti L, Lampasona V, Perseghin G, Magistretti P, Secchi A, Bonifacio E.

Diabetologia. 2011 Feb;54(2):433-9. doi: 10.1007/s00125-010-1959-6. Epub 2010 Nov 3.

PMID:
21046356
35.

Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study.

Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M, Mannino S, Crosignani P, Bosi E, Luzi L, Ruotolo G, Perseghin G.

Diabetes Care. 2011 Jan;34(1):210-5. doi: 10.2337/dc10-0665. Epub 2010 Oct 11.

36.

Left ventricular function and energy homeostasis in patients with type 1 diabetes with and without microvascular complications.

Perseghin G, Lattuada G, De Cobelli F, Esposito A, Canu T, Ragogna F, Maffi P, Scifo P, Secchi A, Del Maschio A, Luzi L.

Int J Cardiol. 2012 Jan 26;154(2):111-5. doi: 10.1016/j.ijcard.2010.09.010. Epub 2010 Oct 5.

PMID:
20926147
37.

[Ageing and cardiac function. Is there a role of physical exercise?].

Perseghin G.

Recenti Prog Med. 2010 Jun;101(6):232-4. Italian.

PMID:
20672565
38.

The role of non-alcoholic fatty liver disease in cardiovascular disease.

Perseghin G.

Dig Dis. 2010;28(1):210-3. doi: 10.1159/000282088. Epub 2010 May 7. Review.

PMID:
20460913
39.

Viewpoints on the way to a consensus session: where does insulin resistance start? The liver.

Perseghin G.

Diabetes Care. 2009 Nov;32 Suppl 2:S164-7. doi: 10.2337/dc09-S303. Review. No abstract available.

40.

Free leptin index and thyroid function in male highly trained athletes.

Perseghin G, Lattuada G, Ragogna F, Alberti G, La Torre A, Luzi L.

Eur J Endocrinol. 2009 Dec;161(6):871-6. doi: 10.1530/EJE-09-0569. Epub 2009 Sep 22.

PMID:
19773373
41.

A high carbohydrate meal yields a lower ischemic threshold than a high fat meal in patients with stable coronary disease.

Fragasso G, Montano C, Lattuada G, Salerno A, Palloshi A, Calori G, Luzi L, Perseghin G, Margonato A.

Int J Cardiol. 2011 Mar 3;147(2):209-13. doi: 10.1016/j.ijcard.2009.08.023. Epub 2009 Sep 18.

PMID:
19766332
42.

Elevated fasting plasma C-peptide occurs in non-diabetic individuals with fatty liver, irrespective of insulin resistance.

Perseghin G, Caumo A, Lattuada G, De Cobelli F, Ntali G, Esposito A, Belloni E, Canu T, Ragogna F, Scifo P, Del Maschio A, Luzi L.

Diabet Med. 2009 Sep;26(9):847-54. doi: 10.1111/j.1464-5491.2009.02785.x.

PMID:
19719704
43.

Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals.

Piemonti L, Calori G, Lattuada G, Mercalli A, Ragogna F, Garancini MP, Ruotolo G, Luzi L, Perseghin G.

Diabetes Care. 2009 Nov;32(11):2105-10. doi: 10.2337/dc09-0763. Epub 2009 Jul 29.

44.

Effect of L-acetylcarnitine on body composition in HIV-related lipodystrophy.

Benedini S, Perseghin G, Terruzzi I, Scifo P, Invernizzi PL, Del Maschio A, Lazzarin A, Luzi L.

Horm Metab Res. 2009 Nov;41(11):840-5. doi: 10.1055/s-0029-1225625. Epub 2009 Jul 13.

PMID:
19598076
45.

Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy.

De Cobelli F, Esposito A, Belloni E, Pieroni M, Perseghin G, Chimenti C, Frustaci A, Del Maschio A.

AJR Am J Roentgenol. 2009 Mar;192(3):W97-102. doi: 10.2214/AJR.08.1201.

PMID:
19234246
46.

MRI of cardiomyopathy.

Belloni E, De Cobelli F, Esposito A, Mellone R, Perseghin G, Canu T, Del Maschio A.

AJR Am J Roentgenol. 2008 Dec;191(6):1702-10. doi: 10.2214/AJR.07.3997.

PMID:
19020239
47.

Left ventricular function and energy metabolism in middle-aged men undergoing long-lasting sustained aerobic oxidative training.

Perseghin G, De Cobelli F, Esposito A, Belloni E, Lattuada G, Canu T, Invernizzi PL, Ragogna F, La Torre A, Scifo P, Alberti G, Del Maschio A, Luzi L.

Heart. 2009 Apr;95(8):630-5. doi: 10.1136/hrt.2008.154716. Epub 2008 Nov 13.

PMID:
19008274
48.

Insulin resistance to both glucose and aminoacid metabolism in a patient with Fatal Familial Insomnia.

Benedini S, Cortelli P, Caumo A, Terruzzi I, Beelke M, Perseghin G, Montagna P, Lugaresi E, Luzi L.

Nutr Metab Cardiovasc Dis. 2008 Nov;18(9):e47-8. doi: 10.1016/j.numecd.2008.08.003. Epub 2008 Sep 16. No abstract available.

PMID:
18799296
49.

Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.

Esposito A, De Cobelli F, Perseghin G, Pieroni M, Belloni E, Mellone R, Canu T, Gentinetta F, Scifo P, Chimenti C, Frustaci A, Luzi L, Maseri A, Maschio AD.

Heart. 2009 Mar;95(3):228-33. doi: 10.1136/hrt.2008.142562. Epub 2008 Aug 15.

PMID:
18708417
50.

Is a nutritional therapeutic approach unsuitable for metabolically healthy but obese women?

Perseghin G.

Diabetologia. 2008 Sep;51(9):1567-9. doi: 10.1007/s00125-008-1077-x. No abstract available.

PMID:
18581090

Supplemental Content

Loading ...
Support Center